GlassScriptPhysician profile
Mansel Kevwitch
NPI 1568540771
$9,069.27
in general payments reported to CMS, 2019-2025
39 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,401 · 2020: $1,052 · 2021: $535 · 2022: $802 · 2023: $3,396 · 2024: $1,735 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,548 · Travel and Lodging: $1,631 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,548.45 |
| Travel and Lodging | $1,630.59 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,990.37 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Myriad Genetic Laboratories, INC. | $1,333.05 | 2020-2025 | Prolaris |
| Boston Scientific Corporation | $1,234.80 | 2019-2024 | Ams 700 |
| Janssen Biotech, INC. | $989.98 | 2019-2024 | Erleada, Rybrevant, Darzalex |
| Telix Pharmaceuticals | $343.97 | 2024-2025 | Illuccix |
| Janssen Scientific Affairs, LLC | $239.93 | 2023 | Erleada |
| Sumitomo Pharma America, INC. | $223.67 | 2023-2024 | Gemtesa, Orgovyx |
| Pfizer INC. | $220.07 | 2019 | |
| Ferring Pharmaceuticals INC. | $204.93 | 2019-2020 | |
| Rochester Medical Corporation | $202.49 | 2020 | |
| 180 Medical, INC. | $186.09 | 2019-2024 | |
| Accord Healthcare, INC. | $170.15 | 2023-2024 | |
| Palette Life Sciences, INC. | $167.51 | 2023 | |
| Organogenesis INC. | $163.09 | 2023-2024 | Puraply, Affinity, Apligraf |
| Urogen Pharma, INC. | $146.77 | 2021-2024 | Jelmyto |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $110.94 | 2019 | |
| Coloplast Corp | $102.93 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.56 | 2019-2024 | |
| Astellas Pharma US INC | $97.85 | 2019-2020 | |
| Dentsply Ih INC. | $92.27 | 2020 | |
| Travere Therapeutics, INC. | $92.06 | 2019-2020 | |
| Olympus America INC. | $69.61 | 2019-2022 | |
| Ambu INC. | $69.07 | 2022-2024 | |
| Abbvie INC. | $63.97 | 2019 | |
| Urovant Sciences INC | $59.24 | 2022 | |
| Merck Sharp & Dohme LLC | $47.92 | 2023 | Welireg, Keytruda, Lynparza |
| Profound Medical Corp. | $40.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $37.90 | 2022-2023 | Lynparza |
| Sun Pharmaceutical Industries INC. | $32.36 | 2022-2023 | Yonsa, Odomzo |
| Immunitybio, INC. | $31.13 | 2024 | |
| Glaxosmithkline, LLC. | $29.94 | 2023 | Zejula, Jemperli |
| Myovant Sciences INC. | $27.65 | 2021-2022 | |
| Convatec INC. | $26.63 | 2021 | |
| Amgen INC. | $25.10 | 2020 | |
| Therapeuticsmd, INC. | $25.00 | 2020 | |
| Lilly USA, LLC | $21.51 | 2023 | |
| Hollister Incorporated | $20.46 | 2022 | |
| Abc Home Medical Supply, INC. | $16.95 | 2022 | |
| Blueprint Medicines Corporation | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansel Kevwitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.